Grasse – France Sitemap FIGO score calculationGuidelinesChemotherapyEMA-CO and EMA-EPMonochemotherapyPolychemotherapiesCHUM Chemo ProtocolsHydatidiform molesMoles and pregnanciesPartial/complete molesPost mole follow-upNeoplasiasLow risk GTNRecurrent GTNsGTN ultra/high riskPost-GTN follow-upPSTT and ETTSOGC/GOC DirectivePractice ChangesSummary declarationsKey messagesRecommendationsOops, a 404 error has occurred…Network of Trophoblastic Diseases of QuebecMission of the RMTQOperation – RMTQTeam – RMTQSoftware – RMTQSoftware developmentStatisticsProfessionalsDiagnosticClinical classificationQuiescent GTDPost-molar GTNGTD in numbersPathology and geneticsEPS, PSN and GTNMoles and abortionsOrigins and phenotypesPrinciples of GeneticsßhCGDifferential dx hCGnon-GTN tumor hCGßhCG – normal pregnancyElevated ßhCGFIGO stages and scoresGTN Risk LevelsFIGO scoreFIGO StadiumsResearchRima Slim PhD Lab.Protocols – RMTQAbbreviationsUseful linksPublications – RMTQPatientsNurse CoordinatorTestimonialsBabies – RMTQHydatidiform mole – FAQMalignant disease – FAQTropho NewsDeclare your patientConsent – RMTQConsent archivesRecording – RMTQContact U.SLegal NoticeMake a donationSitemapConfidentiality Modified on 12/24/2023
